atomoxetine hydrochloride has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biaggioni, I; Black, BK; Diedrich, A; Gamboa, A; Okamoto, LE; Raj, SR; Robertson, D; Shibao, CA | 1 |
| Biaggioni, I; Black, BK; Choi, L; Diedrich, A; Gamboa, A; Raj, SR; Robertson, D; Shibao, C | 1 |
2 trial(s) available for atomoxetine hydrochloride and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.
Topics: Adult; Atomoxetine Hydrochloride; Autonomic Nervous System Diseases; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Male; Pyridostigmine Bromide; Single-Blind Method; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function.
Topics: Adrenergic Uptake Inhibitors; Aged; Atomoxetine Hydrochloride; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular System; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine Plasma Membrane Transport Proteins; Posture; Propylamines; Systole | 2007 |